Back to News
Market Impact: 0.15
AI and Tech Selloff Heats Up: Buy Big Pharma Stock LLY as a Safe Haven?
Source: zacks.com
Artificial IntelligenceHealthcare & BiotechInvestor Sentiment & PositioningCompany Fundamentals
An AI-driven selloff is prompting investors to seek safe-haven stocks, and the article suggests considering Eli Lilly for value and growth beyond AI. It provides no valuation figures, growth estimates, or market-reaction data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
LLY0.35
More News
- HALOZYME REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
- We're booking big profits in 2 outperformers in Thursday's terrible market
- Cathie Wood’s ARK sells Broadcom stock, buys Nvidia and SpaceX
- Magnificent 7 loses $1 trillion. The most eye-popping stats from Thursday's tech stock plunge
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Wall Street’s best post-midterm rally in 44 years lasted just one day—then $3 trillion vanished as chip stocks plunged over AI fears
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- How to Use AI for an Initiating Coverage Report
- The Great Divergence: North American Banking at the Crossroads of Monetary Policy and Agentic AI (Q4 2025 Bank Earnings)